2seventy bio to Participate in Upcoming Investor Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- 2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, announced today that members of the management team will participate in a fireside chat at the upcoming Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14, 2023 at 6:20pm ET in Dana Point, CA.

A live webcast will be available via the Investors and Media section of 2seventy bio’s website at https://ir.2seventybio.com/. A replay will be archived on 2seventy bio’s site for 30 days following the event.

About 2seventy bio

Our name, 2seventy bio, reflects why we do what we do - TIME. Cancer rips time away, and our goal is to work at the maximum speed of translating human thought into action – 270 miles per hour – to give the people we serve more time. We are building the leading immuno-oncology cell therapy company, focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape.

With a deep understanding of the human body’s immune response to tumor cells and how to translate cell therapies into practice, we’re applying this knowledge to deliver next generation cellular therapies that focus on a broad range of hematologic malignancies, including the first FDA-approved CAR T cell therapy for multiple myeloma, as well as solid tumors. Our research and development is focused on delivering therapies that are designed with the goal to “think” smarter and faster than the disease. Importantly, we remain focused on accomplishing these goals by staying genuine and authentic to our “why” and keeping our people and culture top of mind every day.

For more information, visit www.2seventybio.com.

Follow 2seventy bio on social media: Twitter and LinkedIn.

2seventy bio is a trademark of 2seventy bio, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230607005515/en/

Media & Investors:
Jenn Snyder
617-448-0281
[email protected]

Morgan Adams
774-313-9852
[email protected]

Source: 2seventy bio, Inc.

You May Also Be Interested In

• RS2 Financial Services GmbH Selected to Participate in ECB Digital Euro Pilot
• ICE’s North American Financial Natural Gas Markets Reach Record Open Interest as Customers Manage Supply and Demand Dynamics Across Natural Gas Hubs
• PropXBT Launches Multi-Asset Simulated Trading Platform Featuring Crypto, Forex, Stocks and Commodities Challenges